Ads
related to: meloxicam and canker sores medication
Search results
Results from the WOW.Com Content Network
Kank-A is an American brand of liquid pharmaceutical product marketed by Blistex used primarily to treat canker sores. [1] It is applied directly on the sore and works by numbing the local area (with benzocaine) to prevent discomfort and forming a protective mucous barrier with a compound benzoin tincture that protects the ulcer from further irritation, allowing it to heal more rapidly.
Canker sores. Officially known as aphthous ulcers, these are small sores that appear inside your mouth, commonly on the inner lip, but sometimes on the roof of your mouth or under your tongue ...
Aphthous stomatitis, [2] or recurrent aphthous stomatitis (RAS), commonly referred to as a canker sore or salt blister, is a common condition characterized by the repeated formation of benign and non-contagious mouth ulcers (aphthae) in otherwise healthy individuals.
Meloxicam has been shown, especially at low therapeutic doses, to selectively inhibit COX-2 over COX-1. [9] Meloxicam concentrations in synovial fluid range from 40% to 50% of those in plasma. The free fraction in synovial fluid is 2.5 times higher than in plasma, due to the lower albumin content in synovial fluid compared to plasma.
Aphthous stomatitis (canker sores) is the recurrent appearance of mouth ulcers in otherwise healthy individuals. The cause is not completely understood, but it is thought that the condition represents a T cell mediated immune response which is triggered by a variety of factors.
Diagramatic representation of mucosal erosion (left), excoriation (center), and ulceration (right) Simplistic representation of the life cycle of mouth ulcers. An ulcer (/ ˈ ʌ l s ər /; from Latin ulcus, "ulcer, sore") [2] is a break in the skin or mucous membrane with loss of surface tissue and the disintegration and necrosis of epithelial tissue. [3]
This is a list of drugs and substances that are known or suspected to cause Stevens–Johnson syndrome This is a dynamic list and may never be able to satisfy particular standards for completeness. You can help by adding missing items with reliable sources .
In the same study, 60 percent of ulcers treated with Debacterol had disappeared by day six compared to about 30 percent in the other treatment groups. [4] Sulfonated phenolics/sulfuric acid appears to be more effective on sores in areas of the mouth that produce less saliva. Since a sore must be dry prior to application of Debacterol, it is ...
Ads
related to: meloxicam and canker sores medication